UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000022239
Receipt number R000025616
Scientific Title Efficacy and safety of thrice-weekly insulin degludec in elderly patients with type 2 diabetes
Date of disclosure of the study information 2016/05/08
Last modified on 2018/07/18 12:44:13

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Efficacy and safety of thrice-weekly insulin degludec in elderly patients with type 2 diabetes

Acronym

Thrice-weekly insulin degludec regimen

Scientific Title

Efficacy and safety of thrice-weekly insulin degludec in elderly patients with type 2 diabetes

Scientific Title:Acronym

Thrice-weekly insulin degludec regimen

Region

Japan


Condition

Condition

Type 2 diabetes

Classification by specialty

Endocrinology and Metabolism

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

The aim of this study was to investigate the efficacy and safety of thrice-weekly insulin degludec (IDeg) therapy in elderly patients with type 2 diabetes who need insulin therapy but cannot perform self-injection.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Glycemic controlassessed by continuous glucose monitoring over 7 days

Key secondary outcomes

The percent duration of hypo- (<70 mg/dL and hyper- (>200 mg/dL) glycemia


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

Active

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

After becoming stable on once-daily insulin degludec treatment, OD group was assigned to continue once-daily injection.

Interventions/Control_2

After becoming stable on once-daily insulin degludec treatment, TW group was switched to thrice-weekly injection.
IDeg was injected at twice the OD dose before lunch on Monday, Wednesday, and Friday.

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

100 years-old >

Gender

Male and Female

Key inclusion criteria

The inclusion criteria were the following relative indications for insulin treatment according to the Japan Diabetes Society: 1) detection of marked hyperglycemia (e.g., fasting plasma glucose > 250 mg/dL or casual plasma glucose > 350 mg/dL) in the non-insulin-dependent state, 2) failure to achieve good glycemic control with oral hypoglycemic agents, 3) deterioration of the nutritional status in a lean patient, or 4) to achieve active control of glucose toxicity when this is needed.

Key exclusion criteria

The exclusion criteria were the following absolute indications for insulin treatment: 1) an insulin-dependent state, 2) diabetic coma, 3) hyperglycemia complicated by severe liver or kidney disease, 4) serious infection, trauma, or major surgery, 5) intravenous alimentation. Patients who had no difficulty performing self-injection of insulin were also excluded.

Target sample size

20


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Yasushi Tanaka

Organization

St. Marianna University School of Medicine

Division name

Division of Metabolism and Endocrinology, Department of Internal Medicine

Zip code


Address

2-16-1 Sugao, Miyamae-ku, Kawasaki, Kanagawa 216-8511, Japan

TEL

0449778111

Email

smu.tainai@gmail.com


Public contact

Name of contact person

1st name
Middle name
Last name Yoshio Nagai

Organization

St. Marianna University School of Medicine

Division name

Division of Metabolism and Endocrinology, Department of Internal Medicine

Zip code


Address

2-16-1 Sugao, Miyamae-ku, Kawasaki, Kanagawa 216-8511, Japan

TEL

0449778111

Homepage URL


Email

ynagai@marianna-u.ac.jp


Sponsor or person

Institute

St. Marianna University School ofMedicine

Institute

Department

Personal name



Funding Source

Organization

Self funding

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2016 Year 05 Month 08 Day


Related information

URL releasing protocol


Publication of results

Published


Result

URL related to results and publications

https://www.jstage.jst.go.jp/article/endocrj/63/12/63_EJ16-0252/_article

Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2014 Year 11 Month 01 Day

Date of IRB


Anticipated trial start date

2014 Year 11 Month 18 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2016 Year 05 Month 08 Day

Last modified on

2018 Year 07 Month 18 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000025616


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name